Daniel Yerace
Founder at VININGS HOLDINGS INC.
Net worth: 300 150 $ as of 2024-03-30
Profile
Daniel Yerace is the founder of Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. He is currently the Director & Vice President-Operations at Coeptis Therapeutics Holdings, Inc. Previously, he worked as a Senior Director-Global Supply Chain at Kadmon Pharmaceuticals LLC.
Yerace holds an undergraduate degree and an MBA from Waynesburg University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-21 | 1,010,605 ( 2.80% ) | 300 150 $ | 2024-03-30 |
Daniel Yerace active positions
| Companies | Position | Start |
|---|---|---|
| VININGS HOLDINGS INC. | Founder | - |
| COEPTIS THERAPEUTICS HOLDINGS, INC. | Chief Operating Officer | 2022-10-27 |
Coeptis Pharmaceuticals, Inc.
 Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Coeptis Pharmaceuticals, Inc. operates as a biopharmaceutical firm. It develops Consensi, a combination drug that is indicated for the treatment of osteoarthritis (OA) pain and hypertension. The company was founded by Dave Mehalick, Christine Sheehy, and Dan Yerace and is headquartered in Wexford, PA. | Founder | - |
Former positions of Daniel Yerace
| Companies | Position | End |
|---|---|---|
Kadmon Pharmaceuticals LLC
 Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Corporate Officer/Principal | - |
Training of Daniel Yerace
| Waynesburg University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Coeptis Therapeutics, Inc.
 Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coeptis Therapeutics, Inc. is a pharmaceutical company focused on the development of therapeutics and technologies to disrupt conventional treatment paradigms. Its product portfolio includes CD38-GEAR-NK and a CD38-Diagnostic, which is focused on CD38-related cancers. The company was founded on February 15, 1996 and is headquartered in Wexford, PA. | Health Technology |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Health Technology |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Coeptis Pharmaceuticals, Inc. operates as a biopharmaceutical firm. It develops Consensi, a combination drug that is indicated for the treatment of osteoarthritis (OA) pain and hypertension. The company was founded by Dave Mehalick, Christine Sheehy, and Dan Yerace and is headquartered in Wexford, PA. | Health Technology |
| Coeptis Therapeutics Holdings, Inc. |
- Stock Market
- Insiders
- Daniel Yerace
